Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Salsalate
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Study Phase : Phase IV
Sponsor : Kuhnil Pharmaceutical, Co. Ltd
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 19, 2017
Lead Product(s) : Salsalate
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Highest Development Status : Phase IV
Sponsor : Kuhnil Pharmaceutical, Co. Ltd
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Salsalate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Bristol Myers Squibb
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Efficacy of Salsalate to Treat Endothelial Dysfunction in HIV-infected Adults
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 12, 2010
Lead Product(s) : Salsalate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Bristol Myers Squibb
Deal Size : Inapplicable
Deal Type : Inapplicable